AISA Pharma Announces Completion of Enrollment in Phase 2 RECONNOITER Trial of AISA-021 in Systemic Sclerosis-Related Raynaud's Phenomenon

Aisa Pharma, Inc. a private, clinical-stage biopharmaceutical company announced the completion of enrollment in the ...